Please assess the completion status of the following clinical trial:

Trial Title: Acupuncture for Pain Control in the Emergency Department

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged over 19 years with acute pain defined as pain occurring within 72 hours of ED presentation~* Acute neck pain with no evidence of neurological abnormality~* Acute headache which meets the classification criteria of a primary headache as described by the International Headache Society (code 1 to 4)~* Acute ankle injury with no evidence of fracture or complete tear of ligaments~Exclusion Criteria:~* Any suspected non-musculoskeletal cause (neoplasm or neurological complications) for neck or ankle pain~* Any suspected secondary headaches classified by codes 5 to 12 in the International Classification of Headache Disorders, 2nd edition~* Pain due to bone fracture or joint dislocation~* Pain with fever (defined by a temperature above 37.5 °C)~* Inappropriate at the ED physician's discretion~* Pain level of less than 4 points of pain intensity on the Numerical Rating Scale (NRS) (range 0 to 10) at the completion of observations after the standard ED management~* Pregnant women

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard ED management alone (Type: ACTIVE_COMPARATOR): Radiographic and physical examinations to exclude fractures or other serious conditions will be performed for all patients before considering eligibility in the study. After completion of the examination, patients who have pain of at least a level 4, as measured by the Wong-Baker scale (ranges 0 to 10), will receive intravenous or intramuscular injections of non-steroidal anti-inflammatory drugs (NSAIDs) for immediate pain control. All patients will be observed 30 minutes after the administration of the NSAIDs. In patients with primary headaches who respond poorly to the initial NSAID injection, an intravenous injection of opioid analgesics will be provided. After these initial standard ED management interventions, patients who are still suffering from acute pain will be asked to participate in the trial. During the study, rescue medication for immediate pain control will be allowed for patients allocated to both groups.
- Acupuncture plus standard ED management (Type: EXPERIMENTAL): The patients in this group will receive a single session of individualized acupuncture treatment delivered by a certified Korean Medicine Doctor (KMD) specialized (or in-training) in acupuncture and moxibustion medicine and with at least 3 years of clinical experience. The acupuncture formulas will be composed based on the individual patient's symptoms and at the KMD's discretion. Acupuncture treatments will be provided in line with standard ED management, the same as in the control group.

Based on this trial design, predict the completion outcome and termination type (if applicable).